Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
COVID-19 bij MS: 'The Dutch experience'
jul 2020 | Multipele Sclerose